Sengenics is a functional proteomics company utilizing its proprietary KVIP® protein array technology to discover autoantibody biomarkers for precision medicine. Supporting oncology, autoimmune, and neurology therapeutic pipelines, Sengenics provides unique insights into the immune system's response to disease, facilitating patient stratification and drug safety evaluation.